CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 598 enrolled
Drug / intervention
Digital weight loss interventionbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04551872
NCT04551872N/ACompleted

Personalizing Cardiovascular Health: A Population Approach to Promoting CVD Resistance and Resilience Among Individuals With Obesity

Duke University·interventional·Posted Sep 16, 2020·Updated Apr 24, 2024

In Brief

A clinical study evaluating Digital weight loss intervention for Obesity and Cardiovascular Risk Factor. Completed, enrolled 598 participants across 1 site.

Detailed Summary

Obesity is a rapidly growing epidemic that is associated with the development of cardiovascular disease (CVD). However, some individuals with obesity appear to be resistant to CVD, and other individuals demonstrate resilience to obesity and CVD risk factors. The investigator's overall objective is to understand factors contributing to the heterogeneity of CVD resistance and resilience among individuals with obesity at Duke.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedSep 16, 2020
Enrollment StartSep 22, 2020
Primary CompletionMar 22, 2023
Study CompletionMar 22, 2024
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 5.8 years ago

Interventions

Digital weight loss interventionbehavioral

Participants with obesity enter into a proven 6 month weight loss program that utilizes health coaching and goal-setting. It is a remote intervention that is delivered entirely over their phones. Participants will also receive a FitBit and electronic scale.